Novanta NOVT Medical Solutions — Gross Profit
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Novanta in its filing.
Tagged under the XBRL concept us-gaap:GrossProfit.
The official record: Novanta’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Novanta's medical solutions — gross profit.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Novanta's medical solutions — gross profit?
- Novanta (NOVT) reported medical solutions — gross profit of $52.18M in Q1 2026.
- How has Novanta's medical solutions — gross profit changed year-over-year?
- Novanta's medical solutions — gross profit increased by 13.5% year-over-year, from $45.96M to $52.18M.
- What is the long-term trend for Novanta's medical solutions — gross profit?
- Over 4 years (2021 to 2025), Novanta's medical solutions — gross profit has grown at a 18.6% compound annual growth rate (CAGR), from $100.89M to $199.7M.
- What does medical solutions — gross profit mean?
- The residual profit remaining after deducting the direct costs of goods and services sold from the total revenue of the Medical Solutions segment. It measures the core production efficiency and pricing power of the segment before operating expenses are considered.